Why the study?
Does intravenous ondansetron reduce the incidence of postoperative nausea and emesis in women undergoing ambulatory gynecologic surgery?
Population
544 women between the ages of 18 and 70 yr undergoing gynecologic surgical procedures with general opioid…
Comparison
Intravenous ondansetron administered prior to… vs Placebo administered prior to induction of…
Design
RCT, Randomized to dose received, stratified according to history of nausea…
Follow-up
24 hours
Authors
Loading...
Supports ondansetron 4- or 8-mg dosing for PONV prophylaxis in ambulatory gynecologic surgery; confirms efficacy versus placebo in this RCT.
Does intravenous ondansetron reduce the incidence of postoperative nausea and emesis in women undergoing ambulatory gynecologic surgery?
Intravenous ondansetron, particularly at 4- and 8-mg doses, is highly effective and well-tolerated for preventing postoperative nausea and emesis in women undergoing ambulatory gynecologic surgery.
McKenzie et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: